1955 Capital
Overview
1955 Capital is a U.S.-based venture capital firm that invests in technologies developed in the Americas and Europe that can help solve China's and the developing world's greatest challenges in areas like energy & environment, food safety & supply, health & education, and sustainable manufacturing . The firm's mission is to invest in advanced technologies with the potential to solve these pressing global problems .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nature's Fynd | Jul 2021 | Series C | - |
| Gridtential Energy | Apr 2021 | Convertible Debt | Lead |
| Noah Medical | Apr 2023 | Series B | - |
| Crop Enhancement | Apr 2020 | Series B | Co-investor |
Key People
Andrew Chung
Founder and Managing Partner
Vijit Sabnis
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 1955 Capital based?
Headquarters information for 1955 Capital is not publicly available.
When was 1955 Capital founded?
1955 Capital was founded in 2015.
How many portfolio companies does 1955 Capital have?
1955 Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in 1955 Capital's portfolio?
Portfolio companies visible on Caplight include Nature's Fynd, Gridtential Energy, Noah Medical, Crop Enhancement.
What was 1955 Capital's most recent investment shown here?
1955 Capital's most recent investment in this portfolio sample was in Noah Medical in 2023.
What sectors does 1955 Capital focus on?
1955 Capital focuses on Healthcare & Life Sciences, Energy & Sustainability, Consumer & Commerce, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does 1955 Capital focus on?
1955 Capital typically invests at the Mid stage.
What is 1955 Capital's AUM?
1955 Capital's assets under management are estimated between $100.0M and $250.0M.